Divalproex Sodium
Brand name: Divalproex Sodium
Rank #154 of 500 drugs by total cost
$103.4M
Total Cost
1,921,840
Total Claims
$103.4M
Total Cost
41,061
Prescribers
$54
Cost per Claim
167,976
Beneficiaries
2,244,145
30-Day Fills
$2,518
Avg Cost/Provider
47
Avg Claims/Provider
About Divalproex Sodium
Divalproex Sodium (sold as Divalproex Sodium) was prescribed 1,921,840 times by 41,061 Medicare Part D providers in 2023, costing the program $103.4M. At $54 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 151 | Ipratropium/Albuterol Sulfate (Combivent Respimat) | $108.3M | 353,594 |
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology